6.79
Electrocore Inc stock is traded at $6.79, with a volume of 38,266.
It is up +3.66% in the last 24 hours and up +10.59% over the past month.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
See More
Previous Close:
$6.55
Open:
$6.66
24h Volume:
38,266
Relative Volume:
0.50
Market Cap:
$54.89M
Revenue:
$32.03M
Net Income/Loss:
$-13.97M
P/E Ratio:
-4.0204
EPS:
-1.6889
Net Cash Flow:
$-8.25M
1W Performance:
+9.34%
1M Performance:
+10.59%
6M Performance:
+32.10%
1Y Performance:
+9.34%
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ECOR
Electrocore Inc
|
6.79 | 52.95M | 32.03M | -13.97M | -8.25M | -1.6889 |
|
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
electroCore (ECOR) COO receives 70,000-share RSU equity grant - Stock Titan
electroCore (ECOR) ex-officer sells 16,072 shares to cover RSU tax - Stock Titan
electroCore (ECOR) COO Michael Fox reports initial ownership - Stock Titan
ElectroCore (ECOR) moves 7.1% higher: Will this strength last? - MSN
Entry Recap: Whats the analyst consensus on electroCore Inc2026 Bull vs Bear & Accurate Intraday Trading Signals - baoquankhu1.vn
Analyst Upgrade: Is electroCore Inc stock a value trapMarket Sentiment Summary & High Conviction Investment Ideas - baoquankhu1.vn
electroCore (ECOR) Rises 7.1%: Can This Momentum Continue? - Bitget
electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last? - Yahoo Finance
Shorts Report: Will electroCore Inc outperform during market rallies2026 Sector Moves & AI Driven Price Forecasts - baoquankhu1.vn
Bond Watch: Whats the outlook for electroCore Incs sector2026 Price Swings & Reliable Price Breakout Alerts - baoquankhu1.vn
electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference - Bitget
electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD - Sahm
ElectroCore (ECOR) Advances PTSD Treatment Study - GuruFocus
ElectroCore Announces First Patient Enrollmen - Moomoo
electroCore Inc. R (43E0.F) Q2 FY2025 earnings call transcript - Yahoo Finance
electroCore, Inc. (ECOR) stock price, news, quote and history - Yahoo Finance UK
electroCore reports study on nerve stimulation for brain injury By Investing.com - Investing.com South Africa
electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD - Sahm
electroCore (ECOR) CFO Joshua Lev receives 45,000 RSU equity grant - Stock Titan
ECOR | electroCore, Inc. Common Stock FinancialsIncome Statement - Quiver Quantitative
electroCore reports study on nerve stimulation for brain injury - Investing.com
ECOR PE Ratio & Valuation, Is ECOR Overvalued - Intellectia AI
Electrocore announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
ElectroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - marketscreener.com
electroCore receives two U.S. patents for nerve stimulation tech By Investing.com - Investing.com South Africa
Momentum Shift: Can electroCore Inc deliver alphaQuarterly Trade Review & Reliable Breakout Stock Forecasts - baoquankhu1.vn
electroCore (ECOR) Secures Two New U.S. Patents for Vagus Nerve Modulation - GuruFocus
electroCore receives two U.S. patents for nerve stimulation tech - Investing.com
electroCore Expands Intellectual Property Portfolio - ChartMill
Published on: 2026-03-28 12:14:09 - baoquankhu1.vn
Growth Value: Whats the analyst consensus on electroCore IncEntry Point & Precise Entry and Exit Recommendations - baoquankhu1.vn
Retail Surge: Is electroCore Inc being accumulated by smart money2026 Chart Watch & AI Optimized Trade Strategies - baoquankhu1.vn
Earnings Beat: Is electroCore Inc stock overvalued or fairly priced2026 Short Interest & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Aug Update: Is electroCore Inc stock a value trap2026 WrapUp & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Aug Retail: Is electroCore Inc stock a value trap2026 Patterns & Reliable Price Action Trade Plans - baoquankhu1.vn
ECOR: Bioelectronic medicine leader with rapid growth, FDA-cleared devices, and expanding wellness portfolio - TradingView — Track All Markets
Market Review: Will electroCore Inc benefit from rate cuts2026 Trends & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
ElectroCore outlines 30% revenue growth potential for 2026 as leadership transition advances - MSN
electroCore Inc (ECOR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
Why Is electroCore, Inc. (ECOR) Stock Down Today? - meyka.com
electroCore Inc (ECOR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - GuruFocus
Hedge Fund Moves: Does electroCore Inc meet Warren Buffetts criteria2026 Catalysts & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Analysts Offer Predictions for electroCore FY2030 Earnings - MarketBeat
CEO Moves: Should value investors consider electroCore IncMarket Risk Analysis & Reliable Entry Point Alerts - baoquankhu1.vn
Electrocore’s gammaCore Pipeline Faces Material Trial Disruption Risks From Regulatory, Enrollment and Operational Challenges - theglobeandmail.com
Analysts Offer Insights on Healthcare Companies: Electrocore (ECOR) and Regeneron (REGN) - The Globe and Mail
ElectroCore FY earnings preview - MSN
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):